Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant Acinetobacter baumannii: Improved Efficacy or Decreased Risk of Nephrotoxicity?

BACKGROUND: Acinetobacter baumannii has been recognized as a cause of nosocomial infection. To date, polymyxins, the last-resort therapeutic agents for carbapenem-resistant A. baumannii (CRAB). Thus, the small number of effective antibiotic options against CRAB represents a challenge to human health...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Infect Chemother
Autori principali: Saelim, Weerayuth, Changpradub, Dhitiwat, Thunyaharn, Sudaluck, Juntanawiwat, Piraporn, Nulsopapon, Parnrada, Santimaleeworagun, Wichai
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2021
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8032916/
https://ncbi.nlm.nih.gov/pubmed/34409786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3947/ic.2021.0007
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi